BREAKTHROUGH BIOSENSOR TECHNOLOGIES

Dimitris is an Electronic Engineering graduate from the University of Southampton. His commitment in photonic science led him to the completion of an MSc in Photonics from Imperial College London and a PhD in photonics at the National Technical University of Athens. Dimitris held various research positions developing photonic technologies for telecommunications computer interconnects and bio-applications at the Centre for Research and Technology Hellas the Aristotle University of Thessaloniki in Greece and more. His passion for innovation in health and medical technologies led him to the founding of bialoom. His technological interests revolve around silicon photonics plasmonics biosensing and point of care diagnostics. Dimitris is an EITHealth alumnus where he was trained in Healthtech innovation and entrepreneurship.

Thanasis is a computer science graduate from Aristotle university of Thessaloniki. He received his Master of Science in networks communication and system architecture from the computer science department of the Aristotle University of Thessaloniki. His diploma thesis focused on the design and experimental characterization of plasmonic waveguides integrated with silicon photonics. To pursue his PhD Thanasis joined the WinPhos research group at the Center for Interdisciplinary Research and Innovation (CIRI) of the Aristotle University of Thessaloniki as a research associate participating in a series of EU funded research projects. Thanasis has been developing silicon photonic and plasmonic based solutions for computer interconnects and biosensing applications for more than 3 years strongly focusing on application-driven R&D. His technological interests include photonic and plasmonic integrated circuits for biosensors and next generation point of care diagnostics.

Paul Goodwin recently retired as the Senior Science Director for Cytiva, a very large, multinational Life Sciences company. He founded Whole Box Innovations LLC, a consulting firm that explores the future of science, technology, and business models that will affect Life Sciences and investigate ways to convert challenges into business opportunities. He has extensive experience in conceiving and bringing new sensor technologies to market. He has been on the faculty for numerous microscopy courses at the Marine Biological Laboratory (MBL) in Woods Hole, MA, and Cold Spring Harbor Laboratories, Cold Spring Harbor, NY, for over 20 years and he is a past-President and Councilor of The Histochemical Society. He resides near Seattle, WA.

Serife graduated from University of Bath with an MEng (Hons) in Electrical and Electronic Engineering in 2015. After graduating, her passion towards improving healthcare led her to become the first Electrical and Electronic Engineer in her department to be offered a funded PhD position in a multidisciplinary research centre: Centre for Sustainable and Circular Technologies (CSCT). As part of CSCT, she did an interdisciplinary PhD towards development of an electrochemical biosensors for microRNA detection and researched in between departments of chemistry, pharmacy and engineering. After finishing her PhD, she took on Scientist position focusing on assay development for industry in UK. She worked for commercial companies such as LumiraDx and Paragraf where she specialized on surface functionalization methodologies for range of detection modes. Serife has joined Bialoom as Senior Scientist and looking forward to sharing her 3 years of experience in biosensors industry to provide solutions for silicon photonics biosensors.

Christia graduated from the University of Cyprus with a Physics degree. Her interest in human health led Christia to choose the master’s program in Biomedical Engineering, of the Cyprus University of Technology, as her next step. The simulation of the performance of optic- fibers, indented to be used as a medical tool, is the object of study of her thesis. Different designs and materials are some of the factors that are taken into consideration. Since 2021 Christia holds the role of Bioengineer at bialoom developing and testing the company’s biosensing systems.

Eleftheria Lampadariou holds a BSc in Physics and a MSc in Chemistry and Technology of Materials from the University of Ioannina. Her MSc thesis focused on the computational design and modelling of light-trapping structures in periodically corrugated planar waveguides for graphene-based photodetection. She subsequently obtained her PhD in Materials Science and Engineering, conducting her research at the Computational Materials Science Laboratory (CMS) of the University of Ioannina. Her doctoral work focused on the design, modelling and optimization of integrated photonic and optoelectronic devices, with particular emphasis on sensing applications. During her PhD, she contributed to several European research projects, with her work and technological interests centered on silicon photonics, plasmonic integrated circuits, slow-light structures, and optical biosensors for next-generation point-of-care diagnostics.

Kyle is a Mechanical Engineer with deep expertise in microfluidics, consumable design, and life science instrumentation. He has led the development of point-of-care consumables at Abbott, Diatron, and Quidel, and directed engineering at Standard BioTools to launch instruments for single-cell analysis, qPCR, protein detection, and cell culture. With broad experience in design transfer, he has worked with manufacturing teams and contract partners across North America, Europe, and Asia to ensure scalable, cost-effective production.

Nic is a biochemist specialising in immunoassay development and trouble-shooting. Both his PhD and postdoctoral work, carried out at Imperial London, involved development of several immunoassays for gastrointestinal hormones. Analytes worked on included Motilin, Glucagon (both pancreatic and entero), Galanin, Growth Hormone Releasing Factor and others. In 1985, he joined Amersham International (lately known as Ortho Clinical Diagnostics) where he helped to develop numerous immunoassays on the Amerlite and Vitros ECi platforms (both of these used enhance chemiluminescence-also introduced the labelled antibody approach in the RIA of FT3 and FT4). He was also responsible for the hand-over of R&D assays to manufacturing and in addition trouble-shooting of new and old assays. Nic published about 100 peer-reviewed papers and chapters in books. He was also involved in drafting the NCCLS guidelines on free thyroxine and also on the panel of experts involved in standardisation of free thyroid hormones. His invention (on immunoassay measurement of free analytes) and actual development of the assays (FT3/FT4 on 3 assay platforms) was responsible for several hundred million pounds of revenue for the company. For his contribution Nic received the prestigious Johnson & Johnson Excellence in Science award. From 2007 until now Nic has been acting as an Immunoasssay consultant helping numerous companies with developing (and help trouble-shoot) immunoassays on a variety of platforms.

Panayiotis is a Mechanical Engineer with PhD in Manufacturing Systems and AI. He has past experience in product testing, certification and Quality management with international multi-million sales of scientific and industrial instrumentation. He has over 20 years experience in the development of disruptive products and managed more than 100 R&D and Industry projects with budgets exceeding 100million Euro. He is the founder and CEO of CyRIC the certified Business Innovation Center (BIC) of Cyprus and Gravity Ventures, a venture building incubator based in Nicosia. His expertise extends from creation of business models for commercialization and investments for early stage Startups and Scale-ups. He is president of the Cyprus Association of Research and Innovation Enterprises (CARIE), member of the Cyprus Business Angels Network (CyBAN), member of the BoD, of the European Business Network (EBN), the Nicosia Chamber of Commerce and Industry (NCCI), the Research Promotion Foundation (RPF) and the Cyprus Academic and Research Network (CyNE).